http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-330013-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
filingDate 1966-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1967-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-330013-A1
titleOfInvention A PROCEDURE FOR COMPOSING A PHARMACEUTICAL PREPARATION.
abstract A process for composing a pharmaceutical preparation, characterized in that it consists of: (a) forming a multiplicity of pearls with medicament, of repeated action, each of which has been prepared by coating a medically acceptable core material (1) with a composition adhesive (2), dispersing on the core material treated with the adhesive an active drug (3) retained on said core material treated with the adhesive by said adhesive composition, coating the drug-coated core with an enteric coating (4), coating said enteric coating with an adhesive composition (5), dispersing on the core covered by the enteric coating an active drug (6) retained on said core with enteric coating by said adhesive composition, and/or (b) forming a multiplicity of pearls with medication, sustained release, each of which is prepared by coating a medically acceptable core material (7) with an adhesive composition (8), dispersing on the core material treated with the adhesive an active medicament (9) retained on said core material treated with the adhesive by said adhesive composition, coating the medicated core with a permeable film (10), said permeable film being coated with an adhesive composition (11), dispersing on the film-coated core material an active medicament (12) retained on said film-coated material by the cited adhesive composition; the adhesive composition (2), (5), (8) and (11) is applied in the form of a syrup comprising from 5% to 15% by weight of acacia gum, from 35% to 45% by weight of sucrose and from 40% to 60% by weight of distilled water; the enteric coating (4) is applied in the form of a solution comprising from 25% to 35% by weight of a resin of the abietic acid type, from 10% to 20% by weight of zein, of a 0 , 05% to 0.5% by weight of a wetting agent, from 40% to 60% by weight of a lower aliphatic alcohol, anhydrous and from 1.0% to 10% by weight of a plasticizer, solution that is still diluted with 80% to 110% by weight of a lower, anhydrous aliphatic alcohol; and said permeable film (10) is applied in the form of a solution comprising from 45% to 55% by weight of shellac with 40% to 50% solid matter, from 4.5% to 5%, 5% by weight of a polyethylene glycol and from 40% to 50% by weight of a low molecular weight aliphatic alcohol; said preparation, if desired, is packaged in capsules for oral administration and, if desired, inert fillers are added in addition. (Machine-translation by Google Translate, not legally binding)
priorityDate 1965-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1257693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416115248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180

Total number of triples: 21.